P. Hohenberger

发表

Clinical, Pathological and Surgical Characteristics of Duodenal Gastrointestinal Stromal Tumor and Their Influence on Survival: A Multi-Center Study

C. Raut, P. Rutkowski, P. Hohenberger, 2012, Annals of Surgical Oncology.

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

S. Sleijfer, F. Collin, M. van Glabbeke, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

P. A. Gardner, A. Caraceni, S. Boriani, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

CT-based response assessment of advanced gastrointestinal stromal tumor: dual energy CT provides a more predictive imaging biomarker of clinical benefit than RECIST or Choi criteria.

P. Apfaltrer, M. Meyer, S. Schönberg, 2013, European journal of radiology.

CLINICAL Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up † the ESMO Guidelines Committee and EURACAN*

E. Álava, A. Cesne, H. Joensuu, 2020 .

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Litière, A. Cesne, H. Joensuu, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.

M. van Glabbeke, M. Glabbeke, A. Cesne, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Álava, E. Wardelmann, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

PALETTE: A randomized, double-blind, phase III trial of pazopanib versus placebo in patients (pts) with soft-tissue sarcoma (STS) whose disease has progressed during or following prior chemotherapy-An EORTC STBSG Global Network Study (EORTC 62072).

J. Blay, A. Cesne, A. D. Dei Tos, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective evaluation of quantitative response parameter in patients with Gastrointestinal Stroma Tumor undergoing tyrosine kinase inhibitor therapy-Impact on clinical outcome.

C. Messiou, M. Meyer, Anna Bartsch, 2024, International journal of cancer.

Twelve versus 36 months of adjuvant imatinib (IM) as treatment of operable GIST with a high risk of recurrence: Final results of a randomized trial (SSGXVIII/AIO).

E. Wardelmann, H. Joensuu, M. Schlemmer, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In-vivo quantification of the revascularization of a human acellular dermis seeded with EPCs and MSCs in co-culture with fibroblasts and pericytes in the dorsal chamber model in pre-irradiated tissue

P. Hohenberger, M. Vitacolonna, E. Roessner, 2016, Cell and Tissue Banking.

Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13)

S. Richter, G. Egerer, M. Augustin, 2024, Cancers.

Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN

J. Martín-Broto, A. Trama, S. Piperno-Neumann, 2024, The Lancet regional health. Europe.

[Gastrointestinal stromal tumors (GIST)--current concepts of surgical management].

E. Wardelmann, P. Hohenberger, P. Reichardt, 2004, Deutsche medizinische Wochenschrift.